Product description

Food supplements for pregnancy, for the management of the risk of miscarriage and preterm birth.Four clinical trials demonstrate safety and efficacy of the original formulation with two of the studies demonstrating efficacy in preventing preterm birth, one highlighting its ability to reduce subchorionic hematoma, and one retrospective study confirming safety in over 600 pregnant women. One retrospective study confirms the efficacy of Aleract  HA in reducing adverse outcomes, including miscarriage. There are three ongoing clinical trials for Aleract  HA.
Read more

Specifications

Categories Food Supplements / Nutraceuticals
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Italy
Product Applications Dietary Supplements; Food Supplements
Product Certifications Quality assurance

More products from LO.LI. PHARMA INTERNATIONAL S.R.L.

Products from other suppliers